What is the Wells score for pulmonary embolism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is the Wells Score?

The Wells score is a validated clinical prediction rule that assigns points to seven clinical variables to stratify patients with suspected pulmonary embolism into probability categories (low, intermediate, or high risk), guiding decisions about D-dimer testing and imaging. 1, 2

Components and Point Values

The Wells score consists of seven variables, each assigned specific point values 1, 3:

  • Clinical signs/symptoms of deep vein thrombosis (leg swelling and pain on palpation): 3 points 1, 3
  • Pulmonary embolism is the number one diagnosis or equally likely as an alternative diagnosis: 3 points 3
  • Heart rate greater than 100 bpm (tachycardia): 1.5 points 3
  • Immobilization for ≥3 days or surgery in the previous 4 weeks: 1.5 points 3
  • Previous deep vein thrombosis or pulmonary embolism: 1.5 points 3
  • Hemoptysis: 1 point 3
  • Active malignancy (treatment within 6 months or palliative): 1 point 3

Risk Stratification Categories

The Wells score categorizes patients into three probability groups 1, 2:

  • Low probability (0-1 points): 3.6% PE prevalence 1, 2
  • Intermediate/moderate probability (2-6 points): 20.5% PE prevalence 1, 2
  • High probability (>6 points): 66.7% PE prevalence 1, 2

Alternative Dichotomous Interpretation

The Wells score can also be dichotomized into two categories 1, 4:

  • PE unlikely (≤4 points): 7.8% PE prevalence 1
  • PE likely (>4 points): 40.7% PE prevalence 1

Clinical Application Algorithm

For low or intermediate probability patients (Wells score ≤6), obtain high-sensitivity D-dimer testing; if negative, PE is safely excluded without imaging 3. When combined with a negative D-dimer, the negative predictive value is 99.5% 2, 3.

For high probability patients (Wells score >6), proceed directly to CT pulmonary angiography without D-dimer testing, as a negative D-dimer will not obviate the need for imaging 1, 3. In these patients, initiate anticoagulation immediately while awaiting imaging 3.

Diagnostic Performance

The Wells score demonstrates superior discriminative ability compared to the Geneva score, with an area under the ROC curve of 0.75-0.85 versus 0.54-0.76 1, 5. The Wells score identifies approximately 73% of patients as low risk, with a PE rate of only 3.0% in this group 1.

The Wells score shows moderate to substantial interrater agreement, with kappa values of 0.54 for trichotomized scoring and 0.72 for dichotomized scoring 4.

Simplified Version

A simplified Wells score assigns only 1 point to each of the seven variables (rather than the weighted scoring above), which has been validated and shows similar safety and clinical utility 6, 7. The simplified version uses a cut-off of ≤1 point for "PE unlikely" and maintains a three-month VTE incidence of 0.5% when combined with normal D-dimer 6, 7.

Critical Pitfalls

Do not use D-dimer testing in high-probability patients (Wells score >6), as it has low negative predictive value in this population and will not change management 1. Do not apply the Wells score in isolation—it must be combined with D-dimer testing (for low/intermediate probability) or imaging (for high probability) to safely exclude or diagnose PE 2, 3.

Related Questions

What is the Wells score for pulmonary embolism (PE) and how is it used in diagnosis and treatment?
How is the Wells score used to diagnose and manage pulmonary embolism?
What is the Wells' score (Wells' score for pulmonary embolism) for assessing pulmonary embolism (PE)?
What is the most recommended scoring system for pulmonary embolism (PE)?
How is the Well's score (Wells' score for pulmonary embolism) calculated?
In a patient with primary hyperparathyroidism and hypercalcemia (serum calcium 11.7 mg/dL), 25‑hydroxy‑vitamin D 29.8 ng/mL, serum creatinine 0.96 mg/dL and estimated glomerular filtration rate 64 mL/min, how should vitamin D be repleted?
In adults with acute cardiogenic shock (often post‑myocardial infarction), what were the efficacy and safety outcomes of milrinone versus dobutamine in the DOREMI trial, and how should the inotrope be selected?
Does creatine monohydrate supplementation cause or exacerbate acne?
What additional medications can be prescribed for a 22‑year‑old man in remission from severe methamphetamine dependence who experiences benign visual pareidolia without psychosis?
What is the most likely diagnosis and immediate management for a 56‑year‑old obese diabetic woman with hypertension and hyperlipidemia who presents with a 3 × 5 cm erythematous, warm, movable, blanching mass on the left lateral breast/axillary region that has been enlarging over 5 days, given her personal history of colon cancer and a sister with early‑onset breast cancer?
Does amlodipine contain lactose (a milk‑derived sugar) that could affect a patient with lactose intolerance or dairy allergy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.